The Effect of Ranibizumab on Normal Neurosensory Retina in the Eyes of Patients with Exudative Age Related Macular Degeneration.
Conclusion: One year treatment with ranibizumab on an individualized, according to need dosing regimen does not seem to induce any detectable structural damage in the unaffected, normal retina.
PMID: 29399233 [PubMed]
Source: Open Ophthalmology Journal - Category: Opthalmology Tags: Open Ophthalmol J Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Brain | Eyes | Lucentis | Neurology | Opthalmology | PET Scan | Ranibizumab Injection | Study | Vitamin A